Investors Sue Infertility Co. OvaScience To Stop Merger Plan
Stockholders challenged a proposed reverse merger in Massachusetts federal court Wednesday that would take biopharmaceutical company Millendo Therapeutics public as it acquires the fledgling female infertility treatment firm OvaScience....To view the full article, register now.
Already a subscriber? Click here to view full article